# Intranasal Dexmedetomidine for Sedated Hearing Testing

> **NCT03530371** · PHASE3 · COMPLETED · sponsor: **Fondation Lenval** · enrollment: 60 (actual)

## Conditions studied

- Auditory Brainstem Response

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride

## Key facts

- **NCT ID:** NCT03530371
- **Lead sponsor:** Fondation Lenval
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-02
- **Primary completion:** 2021-11-16
- **Final completion:** 2021-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03530371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03530371, "Intranasal Dexmedetomidine for Sedated Hearing Testing". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03530371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*